IBO - CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.